Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the "Plan") notified the Company and the under-mentioned person on 10 January 2011 of an increase in his notional interests in Ordinary shares at a price of £12.52 per share following the re-investment of dividends paid to shareholders on 6 January 2011.
Mr A P Witty |
Acquisition of 318 Ordinary shares under the dividend re-investment element of the Plan (personal contribution) |
|
|
|
Acquisition of 318 Ordinary shares under the matching element of the Plan (Company contribution)
|
The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
10 January 2011